Literature DB >> 12027784

SUNCT Syndrome: diagnosis and treatment.

Juan A Pareja1, Ana B Caminero, Ottar Sjaastad.   

Abstract

Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) is a syndrome predominant in males, with a mean age of onset around 50 years. The attacks are strictly unilateral, generally with the pain persistently confined to the ocular/periocular area. Most attacks are moderate to severe in intensity and burning, stabbing or electrical in character. The mean duration of paroxysms is 1 minute, with a usual range of 10 to 120 seconds (total range 5 to 250 seconds). Prominent, ipsilateral conjunctival injection and lacrimation regularly accompany the attacks. Nasal stuffiness/rhinorrhoea are frequently noted. In addition, there is subclinical forehead sweating. During attacks, there is increased intraocular pressure on the symptomatic side and swelling of the eyelids. No changes in pupil diameter have been observed. Attacks can be triggered mostly from trigeminally innervated areas, but also from the extratrigeminal territory. There are also spontaneous attacks. An irregular temporal pattern is the rule, with symptomatic periods alternating with remissions in an unpredictable fashion. During active periods, the frequency of attacks may vary from <1 attack/day to >30 attacks/hour. The attacks predominate during the daytime, nocturnal attacks being seldom reported. A SUNCT-like picture has been described in some patients with either intra-axial or extra-axial posterior fossa lesions, mostly vascular disturbances/ malformations. In the vast majority of patients, however, aetiology and pathogenesis are unknown. In SUNCT syndrome, there is a lack of persistent, convincingly beneficial effect of drugs or anaesthetic blockades that are generally effective in cluster headache, chronic paroxysmal hemicrania, trigeminal neuralgia, idiopathic stabbing headache ('jabs and jolts syndrome'), and other headaches more faintly resembling SUNCT syndrome. Single reports have claimed that carbamazepine, lamotrigine, gabapentin, corticosteroids or surgical procedures may be of help. However, caution is recommended when assessing any therapy in a disorder such as SUNCT syndrome, in which the rather chaotic and unpredictable temporal pattern makes the assessment of any drug/therapeutic effect per se a particularly difficult matter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027784     DOI: 10.2165/00023210-200216060-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  46 in total

1.  Possible usefulness of lamotrigine in the treatment of SUNCT syndrome.

Authors:  G D'Andrea; F Granella; M Cadaldini
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

2.  The Vågå study; epidemiology of headache I: the prevalence of ultrashort paroxysms.

Authors:  O Sjaastad; H Pettersen; L S Bakketeig
Journal:  Cephalalgia       Date:  2001-04       Impact factor: 6.292

Review 3.  Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.

Authors:  F Antonaci; O Sjaastad
Journal:  Headache       Date:  1989-11       Impact factor: 5.887

4.  SUNCT syndrome. Atypical temporal patterns.

Authors:  J A Pareja; J Joubert; O Sjaastad
Journal:  Headache       Date:  1996-02       Impact factor: 5.887

5.  SUNCT syndrome responsive to gabapentin (Neurontin).

Authors:  S B Graff-Radford
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

6.  Migraine: diagnosis and treatment with emphasis on the migraine-tension head-ache, provocative tests and use of rectal suppositories.

Authors:  G A PETERS
Journal:  Proc Staff Meet Mayo Clin       Date:  1953-12-02

7.  Cluster headache--clinical findings in 180 patients.

Authors:  G C Manzoni; M G Terzano; G Bono; G Micieli; N Martucci; G Nappi
Journal:  Cephalalgia       Date:  1983-03       Impact factor: 6.292

8.  A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.

Authors:  C P Watson; K L Tyler; D R Bickers; L E Millikan; S Smith; E Coleman
Journal:  Clin Ther       Date:  1993 May-Jun       Impact factor: 3.393

9.  Chronic paroxysmal hemicrania. VI. Precipitation of attacks. Further studies on the precipitation mechanism.

Authors:  O Sjaastad; D Russell; C Saunte; I Hørven
Journal:  Cephalalgia       Date:  1982-12       Impact factor: 6.292

10.  Chronic paroxysmal hemicrania. X. On the autonomic involvement.

Authors:  O Sjaastad; J Aasly; T Fredriksen; M M Wysocka Bakowska
Journal:  Cephalalgia       Date:  1986-06       Impact factor: 6.292

View more
  7 in total

1.  Swimmer's headache, or supraorbital neuralgia.

Authors:  John C O'Brien
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

Review 2.  Update on the diagnosis and management of trigemino-autonomic headaches.

Authors:  Arne May
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

3.  Refractory Short-Lasting Unilateral Neuralgiform Headache Attacks With Conjunctival Injection and Tearing (SUNCT) Responding to Erenumab Adjuvant Therapy: A Case Report.

Authors:  Vishali Moond; Katherine Hamilton; Rebecca Martinez; Claudia Carrizo; Mark Burish
Journal:  Cureus       Date:  2022-04-23

4.  Cluster Headache and Cluster Variants.

Authors:  Marc E. Lenaerts
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

5.  SUNCT and SUNA: Recognition and Treatment.

Authors:  Juan A Pareja; Mónica Alvarez; Teresa Montojo
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

6.  Craniofacial trauma and double epidural hematomas from horse training.

Authors:  Aaron D Baugh; Reginald F Baugh; Joseph N Atallah; Daniel Gaudin; Mallory Williams
Journal:  Int J Surg Case Rep       Date:  2013-11-07

7.  SUNCT syndrome in a child: a rare cause of paroxysmal headache.

Authors:  Aycan Unalp; Aysel Aydogan Oztürk
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.